Double maintains 1 strategies that include LXRX - Lexicon Pharmaceuticals, Inc.
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| GNOM | 34.76% | $46.47M | 0.5% |
| ARKG | 32.89% | $1.03B | 0.75% |
| XBI | 32.22% | $4.81B | 0.35% |
| IWC | 28.73% | $840.86M | 0.6% |
| IBB | 26.55% | $5.37B | 0.45% |
| PTH | 25.44% | $96.25M | 0.6% |
| IWO | 25.15% | $11.77B | 0.24% |
| PBW | 24.64% | $294.50M | 0.65% |
| IWMY | 24.47% | $120.43M | 1.02% |
| IWM | 24.05% | $65.64B | 0.19% |
| VTWO | 23.92% | $12.65B | 0.07% |
| KOMP | 23.80% | $2.34B | 0.2% |
| ARTY | 23.59% | $1.12B | 0.47% |
| PTLC | 23.53% | $3.32B | 0.6% |
| PINK | 23.52% | $130.30M | 0.5% |
| ARKK | 23.46% | $6.81B | 0.75% |
| AIPI | 23.45% | $326.97M | 0.65% |
| PBE | 23.43% | $226.91M | 0.58% |
| ULTY | 23.13% | $961.00M | 1.3% |
| GSSC | 23.02% | $591.16M | 0.2% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| CALM | -0.01% | $5.37B | +59.42% | 6.69% |
| QNRX | 0.02% | $5.30M | -60.39% | 0.00% |
| ATEX | 0.03% | $451.13M | -41.87% | 0.00% |
| EXR | -0.05% | $31.58B | -6.35% | 4.37% |
| MNOV | 0.06% | $62.29M | -8.63% | 0.00% |
| HCA | -0.07% | $91.01B | +19.15% | 0.74% |
| PCG | -0.08% | $29.76B | -24.61% | 0.63% |
| PSTL | -0.09% | $351.77M | +5.13% | 6.54% |
| CVS | -0.09% | $83.01B | +12.73% | 4.09% |
| MGEE | 0.11% | $3.22B | +12.65% | 2.05% |
| ERJ | 0.12% | $10.00B | +83.64% | 0.00% |
| CHH | -0.15% | $6.25B | +9.40% | 0.86% |
| UNM | 0.15% | $14.03B | +56.25% | 2.08% |
| MCS | -0.16% | $524.16M | +49.35% | 1.62% |
| BBW | -0.17% | $678.92M | +102.92% | 1.64% |
| CRI | 0.17% | $1.21B | -46.78% | 8.09% |
| DSP | 0.17% | $853.41M | +32.56% | 0.00% |
| COOP | -0.17% | $9.49B | +76.30% | 0.00% |
| UNH | 0.18% | $271.70B | -40.62% | 2.85% |
| AVB | 0.19% | $28.86B | -0.08% | 3.43% |
Current Value
$1.131 Year Return
Current Value
$1.131 Year Return
Yahoo
Key Insights The considerable ownership by private equity firms in Lexicon Pharmaceuticals indicates that they...
Yahoo
Oral presentation highlighted the post-hoc analysis during the “Interventions to Prevent Hypoglycemia: Bench to Bedside” session Treatment with sotagliflozin resulted in no increased risk and a reduction in hypoglycemia events, particularly in patients with blood glucose ≤55 mg/dL THE WOODLANDS, Texas, June 23, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced that a post-hoc analysis of clinical study data showing a reduction in hypoglycemic events when sotaglifloz
Yahoo
Oral presentation on study demonstrating the ability of sotagliflozin to reduce the risk of hypoglycemic events regardless of kidney function in people with type 1 diabetesTHE WOODLANDS, Texas, June 18, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that data from a study evaluating the impact of sotagliflozin on hypoglycemia in people with type 1 diabetes will be delivered as an oral presentation on Sunday, June 22, during the 85th Scientific Sessions of t
Finnhub
Denmark's Novo Nordisk is partnering with biotech company Deep Apple Therapeutics in a deal worth up to $812 million to develop drugs for cardiometabolic diseases, including obesity, the...
Yahoo
Merck reports promising response rates for its ADC zilovertamab vedotin in relapsed DLBCL and KRAS inhibitor MK-1084 in solid tumors.
Yahoo
THE WOODLANDS, Texas, May 29, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in a fireside chat at the 2025 Jefferies Global Healthcare Conference, taking place in New York City on Thursday, June 5 at 12:50 p.m. ET. The live event and a replay of the presentation can be accessed via the Events page of the Company’s website at https://investors.lexpharma.com/. About Lexicon Pharmaceuticals Lexicon is a biopharmaceutic
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| BTAL | -23.70% | $315.93M | 1.43% |
| VIXY | -19.90% | $184.73M | 0.85% |
| IYK | -15.07% | $1.44B | 0.4% |
| PSQA | -14.96% | $36.49M | 0.2% |
| TAIL | -14.75% | $94.86M | 0.59% |
| TBIL | -12.71% | $5.76B | 0.15% |
| IBD | -11.09% | $390.98M | 0.43% |
| UNG | -11.05% | $375.27M | 1.06% |
| XLP | -10.81% | $16.01B | 0.09% |
| SHYD | -10.68% | $331.91M | 0.35% |
| VRIG | -9.82% | $1.21B | 0.3% |
| IBMO | -9.71% | $527.22M | 0.18% |
| JMST | -9.40% | $4.09B | 0.18% |
| DFNM | -9.28% | $1.58B | 0.17% |
| FTXG | -9.09% | $22.44M | 0.6% |
| TFLO | -8.93% | $6.74B | 0.15% |
| VDC | -8.78% | $7.63B | 0.09% |
| FSTA | -8.54% | $1.35B | 0.084% |
| TBLL | -8.49% | $2.12B | 0.08% |
| ITM | -7.97% | $1.87B | 0.18% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| NABL | 35.69% | $1.55B | -45.03% | 0.00% |
| EYPT | 35.19% | $761.06M | +11.60% | 0.00% |
| OCUL | 34.97% | $1.77B | +45.79% | 0.00% |
| DNLI | 33.76% | $2.23B | -33.52% | 0.00% |
| AGX | 33.59% | $2.84B | +188.53% | 0.69% |
| RXRX | 32.96% | $2.47B | -25.59% | 0.00% |
| PLRX | 32.19% | $85.94M | -88.80% | 0.00% |
| BEAM | 31.88% | $2.22B | -14.88% | 0.00% |
| NTLA | 31.50% | $1.26B | -50.63% | 0.00% |
| RC | 30.54% | $782.63M | -49.45% | 16.38% |
| FATE | 30.44% | $132.97M | -65.88% | 0.00% |
| DNTH | 30.43% | $662.82M | -28.86% | 0.00% |
| BLNK | 30.27% | $105.80M | -68.79% | 0.00% |
| TREE | 29.20% | $551.15M | -9.85% | 0.00% |
| SYRE | 28.65% | $963.24M | -43.26% | 0.00% |
| ARCT | 28.56% | $392.71M | -39.06% | 0.00% |
| PLSE | 28.53% | $1.15B | +6.14% | 0.00% |
| RYTM | 28.52% | $5.66B | +91.07% | 0.00% |
| IDYA | 28.49% | $2.00B | -42.45% | 0.00% |
| ALEC | 28.12% | $171.99M | -68.21% | 0.00% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| IBTK | 0.02% | $445.94M | 0.07% |
| IBTO | 0.02% | $353.51M | 0.07% |
| SCHO | 0.04% | $10.98B | 0.03% |
| SHLD | 0.09% | $3.05B | 0.5% |
| HIGH | -0.10% | $189.45M | 0.52% |
| CGCB | 0.19% | $2.51B | 0.27% |
| EUSB | 0.20% | $728.10M | 0.12% |
| GOVT | 0.22% | $27.25B | 0.05% |
| CLOA | -0.23% | $942.15M | 0.2% |
| BLV | -0.27% | $5.58B | 0.03% |
| LDUR | 0.30% | $922.12M | 0.5% |
| GSY | 0.32% | $2.73B | 0.22% |
| KRBN | -0.32% | $159.82M | 0.85% |
| IBTP | -0.33% | $142.98M | 0.07% |
| IBDS | -0.35% | $3.14B | 0.1% |
| MUST | -0.45% | $439.44M | 0.23% |
| DFIP | 0.50% | $928.51M | 0.11% |
| LGOV | -0.51% | $664.62M | 0.67% |
| IEF | 0.54% | $34.50B | 0.15% |
| BSCP | 0.56% | $3.25B | 0.1% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| MSEX | -22.24% | $997.80M | -1.54% | 2.41% |
| KO | -20.96% | $300.31B | +10.57% | 2.87% |
| CHD | -19.33% | $24.40B | -4.48% | 1.17% |
| PG | -17.44% | $371.59B | -4.26% | 2.59% |
| PEP | -17.24% | $186.58B | -17.00% | 4.07% |
| MO | -16.37% | $98.62B | +24.36% | 7.00% |
| KMB | -16.22% | $43.78B | -6.43% | 3.77% |
| CLX | -15.93% | $15.76B | -5.19% | 3.83% |
| TR | -14.98% | $2.53B | +20.60% | 1.04% |
| HSY | -14.75% | $33.36B | -11.86% | 3.35% |
| CL | -14.72% | $73.44B | -7.30% | 2.25% |
| ED | -14.56% | $36.42B | +10.51% | 3.36% |
| GIS | -14.50% | $27.86B | -18.70% | 5.88% |
| KDP | -14.38% | $45.70B | +3.76% | 2.75% |
| MIST | -13.91% | $136.87M | +69.54% | 0.00% |
| POST | -13.75% | $6.00B | +0.75% | 0.00% |
| CBOE | -13.25% | $24.55B | +38.09% | 1.08% |
| HRL | -13.02% | $17.34B | +2.17% | 3.65% |
| ROL | -12.28% | $26.96B | +12.66% | 1.16% |
| MKC | -12.15% | $19.44B | +1.76% | 2.45% |
